June three, 2020: On February eleven, 2020, HHS issued a information (PDF, 162 KB) to condition stakeholders holding antiviral drug products and solutions (Tamiflu and Relenza) about added expiry courting extensions for correctly held product. “…According to FDA's review of scientific data, FDA has concluded for unexpected emergency responses that, https://cesarsdszg.activoblog.com/35346691/little-known-facts-about-expired-listing-in-spanish